-- パシフィック・ライム・アンド・セメント(ASX:PLA)は、パプアニューギニアを拠点とする電力会社ディリオ・ガス・アンド・パワーと、セントラル・ライム・アンド・セメント・プロジェクト専用の電力インフラ開発に関する覚書(MOU)を締結した。これは、同社が金曜日にオーストラリア証券取引所に提出した書類で明らかになった。 このMOUは、セントラル州発電所からパシフィック・ライム・アンド・セメントのプロジェクト地域まで、66キロボルトの専用送電線を敷設するための枠組みを両社が構築するものである、と同書類は述べている。 同書類によると、送電線沿いの近隣地域への電力供給は、送電容量と承認状況に応じて拡大される可能性がある。 パシフィック・ライム・アンド・セメントの株価は、金曜日の午後の取引で約2%下落した。
Related Articles
Easou Technology Invests $7.7 Million in Wealth Product Using Idle Top-up Placing Funds
Easou Technology (HKG:2550) said it has subscribed to a $7.7 million wealth management product issued by Huatai International Financial Products, using idle proceeds from its earlier placings, according to a Friday Hong Kong bourse filing.Shares of the digital service firm were down over 1% in Monday's late-morning trade.The investment, guaranteed by Huatai International Financial, carries an annualized return of 1.07% to 5.83% over a term ending March 30, 2027.Easou said the move aims to enhance the utilization efficiency and returns on idle funds while maintaining liquidity.
SSY Group Gets Chinese Regulatory Nod for Production, Registration of Two Products
SSY Group (HKG:2005) said it received Chinese regulatory approval to begin drug production and registration of its diltiazem hydrochloride in injection form, according to a Hong Kong bourse filing Monday.The drug is mainly used to treat a heart condition known as supraventricular tachycardia and the emergency treatment of abnormally high blood pressure during surgery.The firm's propranolol hydrochloride injection was also approved for production and registration by China's National Medical Products Administration.The product is mainly used to treat supraventricular tachyarrhythmias and ventricular arrhythmias.
Amplitude Energy Says Australian Retirement Trust Raises Stake
Amplitude Energy (ASX:AEL) said Australian Retirement Trust raised its stake in the firm to 6.3% as of Friday from 5.1% as of April 2, according to a Monday Australian bourse filing.Australian Retirement Trust now holds nearly 19 million votes in the firm.